Loading...
Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma
Despite the advances in screening protocols and treatment options, hepatocellular carcinoma (HCC) is still considered to be the most lethal malignancy in patients with liver cirrhosis. Moreover, the survival outcomes after failure of first-line therapy for unresectable HCC is still poor with limited...
Saved in:
| Published in: | Vaccines (Basel) |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7712941/ https://ncbi.nlm.nih.gov/pubmed/33086471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8040616 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|